Question 1

What is the average duration of action of the short-acting noncatecholamine agents?

Accepted Answer

A)  1 to 2 hr 
B)  2 to 4 hr 
C)  4 to 6 hr 
D)  6 to 8 hr 
A)  1 to 2 hr 
B)  2 to 4 hr 
C)  4 to 6 hr 
D)  6 to 8 hr

Question 2

What is the dosage for salmeterol MDI?

Accepted Answer

A)  2 puffs every 4 to 6 hr 
B)  1 to 2 puffs four times daily 
C)  2 puffs three times daily 
D)  2 puffs every 12 hr 
A)  2 puffs every 4 to 6 hr 
B)  1 to 2 puffs four times daily 
C)  2 puffs three times daily 
D)  2 puffs every 12 hr

Question 3

Side effects associated with parenteral administration of aminoglycosides include which of the following?
1) Ototoxicity
2) Voice alteration
3) Nephrotoxicity
4) Deafness

Accepted Answer

A) 1 and 3 only 
B) 1, 2, and 3 only 
C) 2 and 4 only 
D) 1, 3, and 4 only 
A) 1 and 3 only 
B) 1, 2, and 3 only 
C) 2 and 4 only 
D) 1, 3, and 4 only

Question 4

Which of the following nebulizers is used to nebulize iloprost?

Accepted Answer

A)  Hudson 
B)  Pari 
C)  I-neb 
D)  Respirgard 
A)  Hudson 
B)  Pari 
C)  I-neb 
D)  Respirgard

Question 5

When administering aerosolized pentamidine, what should the respiratory care practitioner do?
1) Use a nebulizer that produces particles in the 1- to 2-µm mean mass aerodynamic diameter (MMAD) range.
2) Use a nebulizer system with one-way valves and scavenging expiratory filters.
3) Provide isolation and an environmental containment system.
4) Screen patients for human immunodeficiency virus (HIV).

Accepted Answer

A) 1 and 2 only 
B) 2 and 4 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4 
A) 1 and 2 only 
B) 2 and 4 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4

Question 6

What are some common side effects seen with ipratropium bromide (Atrovent)?

Accepted Answer

A)  Tachycardia 
B)  Blood pressure increase 
C)  Cough and dry mouth 
D)  Tolerance 
A)  Tachycardia 
B)  Blood pressure increase 
C)  Cough and dry mouth 
D)  Tolerance

Question 7

When administering acetylcysteine (Mucomyst), the respiratory therapist should be particularly focused on which of the following potential adverse effects?
1) Incompatibility with certain antibiotics when administered together
2) Blurred vision
3) Bronchospasm
4) Airway obstruction due to rapid liquefaction of mucus

Accepted Answer

A) 3 only 
B) 1, 2, and 3 only 
C) 2, 3, and 4 only 
D) 1, 3, and 4 only 
A) 3 only 
B) 1, 2, and 3 only 
C) 2, 3, and 4 only 
D) 1, 3, and 4 only

Question 8

Inhaled zanamivir is indicated for which of the following treatment of uncomplicated respiratory illness?

Accepted Answer

A)  Pharyngitis 
B)  Croup 
C)  Epiglottitis 
D)  Influenza 
A)  Pharyngitis 
B)  Croup 
C)  Epiglottitis 
D)  Influenza

Question 9

Which of the following is NOT considered part of the assessment of severity of symptoms recommended by the NAEPP and GOLD guidelines to modify level or dosage of corticosteroids?

Accepted Answer

A)  Number of exacerbations 
B)  Missed work or school days 
C)  Pulmonary function 
D)  Use of anticholinergics 
A)  Number of exacerbations 
B)  Missed work or school days 
C)  Pulmonary function 
D)  Use of anticholinergics

Question 10

Which of the following terms is used to describe a drug that stimulates a receptor responding to norepinephrine?

Accepted Answer

A)  Sympatholytic 
B)  Anticholinergic 
C)  Cholinergic 
D)  Adrenergic 
A)  Sympatholytic 
B)  Anticholinergic 
C)  Cholinergic 
D)  Adrenergic

Question 11

Which of the following inhaled corticosteroids is a prodrug?

Accepted Answer

A)  Ciclesonide 
B)  Flunisolide 
C)  Budesonide 
D)  Triamcinolone 
A)  Ciclesonide 
B)  Flunisolide 
C)  Budesonide 
D)  Triamcinolone

Question 12

Which phase describes the time course and disposition of a drug in the body based on its absorption, distribution, metabolism, and elimination?

Accepted Answer

A)  Pharmaceutical 
B)  Pharmacognosy 
C)  Pharmacokinetic 
D)  Pharmacodynamic 
A)  Pharmaceutical 
B)  Pharmacognosy 
C)  Pharmacokinetic 
D)  Pharmacodynamic

Question 13

Which of the following are indications for the use of acetylcysteine (Mucomyst)?
1) Treatment of acetaminophen overdose
2) Treatment of excessive, viscous mucus secretions
3) Treatment of aspirin overdose
4) Treatment of purulent mucus secretions by breaking up DNA

Accepted Answer

A) 1 and 2 only 
B) 2 and 4 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4 
A) 1 and 2 only 
B) 2 and 4 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4

Question 14

In addition to nitric oxide, which of the following inhalational agents have been approved by the U.S. Food and Drug Administration for the treatment of pulmonary hypertension?
1) Treprostenil
2) Epoprostenol
3) Iloprost
4) Alprostadil

Accepted Answer

A) 2 only 
B) 1 and 3 only 
C) 1, 2, 3, and 4 
D) 2 and 4 only 
A) 2 only 
B) 1 and 3 only 
C) 1, 2, 3, and 4 
D) 2 and 4 only

Question 15

What are some potential adverse effects with use of adrenergic bronchodilators?
1) Hypokalemia
2) Dizziness
3) Worsening ventilation/perfusion ratio (   )
4) Bradycardia

Accepted Answer

A) 1 and 4 only 
B) 2 and 3 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4 
A) 1 and 4 only 
B) 2 and 3 only 
C) 1, 2, and 3 only 
D) 1, 2, 3, and 4

Question 16

What amount of ipratropium bromide (Atrovent) is delivered by metered dose inhaler?

Accepted Answer

A)  10 mcg/puff 
B)  15 mcg/puff 
C)  17 mcg/puff 
D)  90 mcg/puff 
A)  10 mcg/puff 
B)  15 mcg/puff 
C)  17 mcg/puff 
D)  90 mcg/puff

Question 17

The National Asthma Education and Prevention Program guidelines advocate the use of oral corticosteroids for which of the following?

Accepted Answer

A)  Acute asthma exacerbations 
B)  Maintenance of severe persistent asthma 
C)  Maintenance of moderate to severe persistent asthma 
D)  Maintenance of mild to moderate persistent asthma 
A)  Acute asthma exacerbations 
B)  Maintenance of severe persistent asthma 
C)  Maintenance of moderate to severe persistent asthma 
D)  Maintenance of mild to moderate persistent asthma

Question 18

Short-acting adrenergic bronchodilators are considered what type of agent according to the National Asthma Education and Prevention Program?

Accepted Answer

A)  Antiinflammatory 
B)  Rescue 
C)  Controller 
D)  Mucolytic 
A)  Antiinflammatory 
B)  Rescue 
C)  Controller 
D)  Mucolytic

Question 19

A metered dose inhaler of salmeterol delivers which of the following?

Accepted Answer

A)  131 mcg/puff 
B)  90 mcg/puff 
C)  65 mcg/puff 
D)  25 mcg/puff 
A)  131 mcg/puff 
B)  90 mcg/puff 
C)  65 mcg/puff 
D)  25 mcg/puff

Question 20

Acetylcysteine (Mucomyst) is indicated in which of the following diseases?
1) Acute tracheobronchitis
2) Bronchiectasis
3) Chronic obstructive pulmonary disease (COPD)
4) Asthma

Accepted Answer

A) 1 and 3 only 
B) 1, 2, and 3 only 
C) 3 and 4 only 
D) 2, 3, and 4 only 
A) 1 and 3 only 
B) 1, 2, and 3 only 
C) 3 and 4 only 
D) 2, 3, and 4 only

Exam 35: Airway Pharmacology

What is the average duration of action of the short-acting noncatecholamine agents?

What is the dosage for salmeterol MDI?

Side effects associated with parenteral administration of aminoglycosides include which of the following? 1) Ototoxicity 2) Voice alteration 3) Nephrotoxicity 4) Deafness

Which of the following nebulizers is used to nebulize iloprost?

What are some common side effects seen with ipratropium bromide (Atrovent)?

Inhaled zanamivir is indicated for which of the following treatment of uncomplicated respiratory illness?

Which of the following is NOT considered part of the assessment of severity of symptoms recommended by the NAEPP and GOLD guidelines to modify level or dosage of corticosteroids?

Which of the following terms is used to describe a drug that stimulates a receptor responding to norepinephrine?

Which of the following inhaled corticosteroids is a prodrug?

Which phase describes the time course and disposition of a drug in the body based on its absorption, distribution, metabolism, and elimination?

Which of the following are indications for the use of acetylcysteine (Mucomyst)? 1) Treatment of acetaminophen overdose 2) Treatment of excessive, viscous mucus secretions 3) Treatment of aspirin overdose 4) Treatment of purulent mucus secretions by breaking up DNA

In addition to nitric oxide, which of the following inhalational agents have been approved by the U.S. Food and Drug Administration for the treatment of pulmonary hypertension? 1) Treprostenil 2) Epoprostenol 3) Iloprost 4) Alprostadil

What are some potential adverse effects with use of adrenergic bronchodilators? 1) Hypokalemia 2) Dizziness 3) Worsening ventilation/perfusion ratio ( ) 4) Bradycardia

What amount of ipratropium bromide (Atrovent) is delivered by metered dose inhaler?

The National Asthma Education and Prevention Program guidelines advocate the use of oral corticosteroids for which of the following?

Short-acting adrenergic bronchodilators are considered what type of agent according to the National Asthma Education and Prevention Program?

A metered dose inhaler of salmeterol delivers which of the following?

Acetylcysteine (Mucomyst) is indicated in which of the following diseases? 1) Acute tracheobronchitis 2) Bronchiectasis 3) Chronic obstructive pulmonary disease (COPD) 4) Asthma

History of Respiratory Care

Delivering Evidence-Based Respiratory Care

Quality, Patient Safety, and Communication, and Recordkeeping

Principles of Infection Prevention and Control

Ethical and Legal Implications of Practice

Physical Principles of Respiratory Care

E-Medicine in Respiratory Care

Fundamentals of Respiratory Care Research

The Respiratory System

The Cardiovascular System

Ventilation

Gas Exchange and Transport

Solutions, Body Fluids, and Electrolytes

Acid-Base Balance

Regulation of Breathing

Bedside Assessment of the Patient

Interpreting Clinical and Laboratory Data

Interpreting the Electrocardiogram

Analysis and Monitoring of Gas Exchange

Pulmonary Function Testing

Review of Thoracic Imaging

Flexible Bronchoscopy and the Respiratory Therapist

Nutrition Assessment

Pulmonary Infections

Obstructive Lung Disease: Chronic Obstructive Pulmonary Disease Copd, Asthma, and Related Diseases

Interstitial Lung Disease

Pleural Diseases

Pulmonary Vascular Disease

Acute Respiratory Distress Syndrome

Trauma, Burns and Near Drowning

Lung Cancer

Neuromuscular and Other Diseases of the Chest Wall

Disorders of Sleep

Neonatal and Pediatric Respiratory Disorders

Airway Management

Emergency Cardiovascular Life Support

Humidity and Bland Aerosol Therapy

Aerosol Drug Therapy

Storage and Delivery of Medical Gases

Medical Gas Therapy

Lung Expansion Therapy

Airway Clearance Therapy Act

Respiratory Failure and the Need for Ventilatory Support

Mechanical Ventilators

Physiology of Ventilatory Support

Patient Ventilator Interaction

Initiating and Adjusting Invasive Ventilatory Support

Noninvasive Ventilation

Extracorporeal Life Support Ecls

Monitoring the Patient in the Intensive Care Unit

Discontinuing Ventilatory Support

Neonatal and Pediatric Respiratory Care

Patient Education and Health Promotion

Cardiopulmonary Rehabilitation

Respiratory Care in Alternative Settings

Filters